Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein

Read the full article at contacted.org...

Found and curated by

Management Consulting

Comments

Popular posts from this blog

New Challenges to Operational Efficiencies Because of COVID Protocols

Becoming a Coach Trainer